









Markets
/
Stocks
/
nasdaq-nlsp
/

NLS Pharmaceutics AG

NLSP

0.762USD

0.000

Close 12/24, 13:00（ET）Quotes delayed by 15 min

3.16MMarket Cap

--P/E TTM



NLS Pharmaceutics AG

0.762

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of NLS Pharmaceutics AG to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-14.63%-2.74M

79.02%-1.53M

61.57%-2.39M

4.81%-7.30M

-19.44%-6.21M

21.25%-7.67M

---5.20M

---9.73M

Net income from continuing operations

101.21%55.02K

73.26%-2.04M

41.96%-4.56M

11.90%-7.61M

-6.97%-7.85M

-87.71%-8.64M

---7.34M

---4.60M

Operating gains losses

----

0.00%5.70K

13.44%5.70K

13.58%5.70K

--5.03K

--5.02K

Other non-cash items

-3484.47%-2.54M

364.69%40.85K

-92.24%74.96K

-39.00%-15.43K

2756.74%966.46K

-108.37%-11.10K

--33.83K

--132.68K

Change in working capital

-116.24%-322.52K

50.78%400.21K

207.47%1.99M

-72.94%265.42K

-69.25%646.02K

118.62%980.79K

--2.10M

---5.27M

-Change in receivables

----

--0.00

----

---12.04K

---9.76K

-Change in prepaid expenses

4.18%-322.32K

332.48%687.54K

-190.84%-336.39K

-190.22%-295.74K

-56.80%370.32K

131.33%327.79K

--857.29K

---1.05M

-Change in other current assets

--16.60K

----

-Change in other current liabilities

----

11.40%-42.24K

----

---47.68K

----

Cash from non-recurring investing activities

Cash from operating activities

-14.63%-2.74M

79.02%-1.53M

61.57%-2.39M

4.81%-7.30M

-19.44%-6.21M

21.25%-7.67M

---5.20M

---9.73M

Investing cash flow

Net cash from continuing investing activities

--3.92K

----

--0.00

----

--6.80K

--32.76K

Capital expenditures

--3.92K

----

--0.00

----

--6.80K

--32.76K

Net cash flow from disposal of fixed assets

--3.92K

----

--0.00

----

--6.80K

--32.76K

Cash from non-current investing activities

Net cash flow from investing activities

---3.92K

----

--0.00

----

---6.80K

---32.76K

Financing cash flow

Cash flow from continuous financing activities

135.90%3.85M

--1.19M

-88.17%1.63M

-100.00%0.00

289.13%13.81M

-78.63%3.59M

--3.55M

--16.79M

Net cash flow from debt Issuance/repayment

-88.08%194.72K

---194.72K

38.96%1.63M

100.00%0.00

--1.18M

83.38%-349.82K

--0.00

---2.10M

Net cash flow from common stock issuance/repurchase

--3.87M

--1.38M

-100.00%0.00

105.03%7.28M

-82.34%1.94M

--3.55M

--11.00M

Proceeds from issuance of warrants

--173.12K

----

-100.00%0.00

28196531.58%5.36M

-74.72%2.00M

--19.00

--7.89M

Net cash flow from other financing activities

---386.33K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

135.90%3.85M

--1.19M

-88.17%1.63M

-100.00%0.00

289.13%13.81M

-78.63%3.59M

--3.55M

--16.79M

Net cash flow

Beginning cash balance

-66.53%552.76K

-89.97%897.68K

21.95%1.65M

64.76%8.95M

-80.91%1.35M

5695.69%5.43M

--7.09M

--93.71K

Current period cash flow changes

247.61%1.11M

95.27%-344.92K

-109.93%-753.77K

-78.98%-7.30M

557.23%7.59M

-158.26%-4.08M

---1.66M

--7.00M

Effect of exchange rate changes

----

100.00%0.00

201.71%416.00

-234.63%-416.00

---409.00

101.25%309.00

--0.00

---24.74K

Ending cash balance

85.52%1.67M

-66.53%552.76K

-89.97%897.68K

21.95%1.65M

64.76%8.95M

-80.91%1.35M

--5.43M

--7.09M

Free cash flow

-14.80%-2.74M

----

---2.39M

----

---5.21M

---9.77M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

